A03047 Summary:

BILL NOA03047
 
SAME ASNo Same As
 
SPONSORJones
 
COSPNSROrtiz, Gunther, Jaffee, Raia, Blankenbush
 
MLTSPNSR
 
Amd §6804, Ed L
 
Provides that there shall be a representative of the drug or medical device manufacturer industry on the state board of pharmacy.
Go to top    

A03047 Actions:

BILL NOA03047
 
01/28/2019referred to higher education
01/08/2020referred to higher education
Go to top

A03047 Committee Votes:

Go to top

A03047 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A03047 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          3047
 
                               2019-2020 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 28, 2019
                                       ___________
 
        Introduced  by M. of A. JONES, ORTIZ, GUNTHER, JAFFEE, RAIA, BLANKENBUSH
          -- read once and referred to the Committee on Higher Education
 
        AN ACT to amend the education law, in relation to including a  represen-
          tative  of  the  drug  or  medical device manufacturer industry on the
          state board of pharmacy

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. The opening paragraph of section 6804 of the education law,
     2  as  added  by  chapter  987  of  the laws of 1971, is amended to read as
     3  follows:
     4    A state board of pharmacy shall be appointed by the regents on  recom-
     5  mendation  of  the commissioner for the purpose of assisting the regents
     6  and the department on matters of professional licensing and professional
     7  conduct in accordance with section  sixty-five  hundred  eight  of  this
     8  title.  The board shall be composed of not less than [nine] ten members,
     9  nine of whom shall be pharmacists licensed in this state  for  at  least
    10  five  years, and one of whom shall be a representative of either drug or
    11  medical device manufacturers. An executive secretary to the board  shall
    12  be  appointed  by  the regents on recommendation of the commissioner and
    13  shall be a pharmacist licensed in this state for at  least  five  years.
    14  The board shall have power:
    15    §  2.  This  act  shall take effect on the sixtieth day after it shall
    16  have become a law.
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02824-01-9
Go to top